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Abstract
Background: A series of epidemiologic studies have identified the fungus Alternaria as a major risk factor for asthma. The
airway epithelium plays a critical role in the pathogenesis of allergic asthma. These reports suggest that activated airway
epithelial cells can produce cytokines such as IL-25, TSLP and IL-33 that induce Th2 phenotype. However the epithelium-
derived products that mediate the pro-asthma effects of Alternaria are not well characterized. We hypothesized that
exposure of the airway epithelium to Alternaria releasing cytokines that can induce Th2 differentiation.
Methodology/Principal Finding: We used ELISA to measure human and mouse cytokines. Alternaria extract (ALT-E) induced
rapid release of IL-18, but not IL-4, IL-9, IL-13, IL-25, IL-33, or TSLP from cultured normal human bronchial epithelial cells; and
in the BAL fluids of naı ¨ve mice after challenge with ALT-E. Both microscopic and FACS indicated that this release was
associated with necrosis of epithelial cells. ALT-E induced much greater IL-18 release compared to 19 major outdoor
allergens. Culture of naı ¨ve CD4 cells with rmIL-18 induced Th2 differentiation in the absence of IL-4 and STAT6, and this
effect was abrogated by disrupting NF- kB p50 or with a NEMO binding peptide inhibitor.
Conclusion/Significance: Rapid and specific release of IL-18 from Alternaria-exposed damaged airway epithelial cells can
directly initiate Th2 differentiation of naı ¨ve CD4
+ T-cells via a unique NF-kB dependent pathway.
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Introduction
Asthma is one of the most common health afflictions worldwide.
Approximately 300 million people suffer from asthma, and 70% of
whom have associated allergies [1]. The airway epithelium is the
first line of defense against inhaled allergens. Recently, a large-
scale, consortium-based genomewide association study of over
10,365 persons with physician-diagnosed asthma and about 16000
unaffected control subjects strongly implicated an important role
of epithelial damage in activation of the adaptive immune system
and induction of allergic airway inflammation and asthma [2].
However, relatively little is known about specific environmental
factors that induce epithelial damage and cytokine release that
promote Th2 differentiation and allergic asthma.
Large multicenter studies have evaluated the relationship
between allergic sensitization to outdoor allergens and asthma
[3–5]. The Childhood Asthma Management Program (CAMP)
study of over 1000 children investigated the relationship between
sensitization to inhalant allergens, such as Penicillium, Aspergillus,
Timothy, Bermuda grass, short ragweed and Alternaria, lung
function and bronchial responsiveness. Sensitization to only
Alternaria was associated with bronchial hyperresponsiveness
(p,0.01) [5]. Similarly, in a study of 895 children that examined
the association between asthma and sensitization to allergens such
as Timothy, Bermuda, Ragweed, Tree mix, Alternaria, Penicillium,
Aspergillus, allergy to only Alternaria was associated with increased
risk for asthma at ages 6 and 11 [6]. In the NHANES II study,
5000 persons 6 to 74 years age were tested for allergy to Alternaria,
mixed giant and short ragweed, oak, perennial ryegrass and
Bermuda grass outdoor allergens; asthma was associated with
allergy to only one outdoor allergen, Alternaria [4]. Finally in the
NHANES III study, 12,000 subjects 6 to 59 years were tested for
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7allergy to perennial rye grass, short ragweed, Bermuda grass,
Russian thistle, white oak and Alternaria; allergy to Alternaria was
associated with asthma [3]. Together, these studies performed in
about 21,000 children and adults have reproducibly shown that
sensitization to Alternaria is a key outdoor allergen associated with
asthma. However, to date, the molecular basis of this association
remains a scientific enigma.
The airways in mice and humans contains epithelial and
dendritic cells (DCs) that are the first cells to respond to inhaled
allergens [7,8]. Prior studies have demonstrated the presence of
intraepithelial class II major histocompatibility complex antigen
(Ia)-bearing dendritic cells (DC) in the conducting airways [9–12].
These airway DCs have emerged as key cells that initiate CD4+ T-
cell responses that direct Th2 response in vivo [8,13–15]. The
airway epithelium can produce several cytokines such as thymic
stromal lymphopoietin (TSLP), IL-25 and IL-33 that play a critical
role in induction of Th2 differentiation, nuocyte formation and
induction of allergic asthma [16–20]. The effects of TSLP and IL-
25 require STAT6 and IL-4, and both cytokines work synergis-
tically to promote Th2 differentiation [17,19,20]. However, the
normal airway epithelium is a powerful barrier against the
development of antigen-specific Th2 cells and allergic airway
inflammation [21–23]. We hypothesized that Alternaria is a unique
allergen that rapidly induces damage to the epithelium, releasing
cytokines that promote Th2 differentiation of naı ¨ve T-cells.
In this report, we show that Alternaria extract induces damage to
the airway epithelium, selectively and rapidly releasing IL-18 but
not other Th2-associated cytokines such as IL-4, IL-9, IL-13, IL-
25, IL-33, and TSLP from cultured normal human bronchial
epithelial cells (NHBE) cells, and in the airways of naive mice. We
also show that rIL-18 by itself is sufficient to induce Th2
differentiation.
Results
Alternaria extract, but not other outdoor allergen
extracts, rapidly induces IL-18 release from airway
epithelial cells
Since airway epithelial cells are the first barrier against inhaled
allergens, we first focused our efforts on identifying Th2-inducing
cytokines secreted from Normal Human Bronchial Epithelial
(NHBE) cells culture with ALT-E. NHBE cells were cultured for
15 minutes with Alternaria extract (ALT-E), and the cell
supernatants were examined for IL-4, IL-13, IL-18, IL-33 and
TSLP. ALT-E rapidly induced a 26-fold increase in IL-18 levels;
other Th2-associated cytokine levels were not significantly alterted
(Fig. 1A). Furthermore, ALT-E (30 mg/ml) induced much greater
IL-18 release from NHBE cells compared to same concentration
of 19 major outdoor allergens that were tested in multicenter
epidemiologic studies [3–5], demonstrating a strong specificity of
release (Fig. 1B). To determine the in vivo relevance of IL-18
release from NHBE cells cultured with ALT-E, we examined the
innate effects of intrapulmonary administration of ALT-E in naı ¨ve
mice. Similar to the observations in NHBE cells, ALT-E challenge
induced a 8.6-fold increase in IL-18 levels in BAL fluid 1 hr post
challenge (Fig. 1C) relative to PBS control animals. These data
indicate that ALT-E induces specific release of IL-18 from
epithelial cells.
Alternaria extract rapidly induces epithelial cell necrosis
Next we examined the mechanism of this release of IL-18 from
epithelial cells. Incubation of A549 bronchial epithelial cells with
ALT-E (30 mg/ml) rapidly induced swelling of cells. The cells
became non-adherent, and rounded in 30 min. (Fig. 2A). ALT-E
also induced similar swelling and rounding of NHBE cells (data
not shown). During this early time the cells rapidly released IL-18
as early as 5 min; release plateaued thereafter (Fig. 2B). Release
of IL-18 was not inhibited in the presence of broad spectrum
protease inhibitors (data not shown). Furthermore, other allergens
with high protease activity allergens, such as house dust mite and
American cockroach extracts, failed to induce IL-18 release (data
Figure 1. Rapid release of cytokines from epithelial cells
cultured with ALT-E. (A, B) NHBE cells were cultured with PBS,
ALT-E or other allergens for 15 min, and released cytokines were
quantified. T. Alder, Tag Alder; S. Ragweed, Short Ragweed (n=5 wells
per treatment group). (C) BALF cytokine levels in naı ¨ve mice 60 min
after challenge with 20 mg ALT-E or PBS control (n=4 per group).
doi:10.1371/journal.pone.0030280.g001
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ROS because adding anti-oxidants along with Alt-E failed to
decrease IL-18 release (data not shown). We observed that ALT-E
increased cell permeability for 7AAD (a necrotic cell surface
marker), but the cells poorly bound Annexin V (an apoptosis
marker) (Fig. 2C), indicating that it induces necrosis of epithelial
cells. To determine the in vivo relevance of these observations,
naı ¨ve mice were challenged with ALT-E; this challenge rapidly
induced exfoliation of dead epithelial cells from the lungs of mice
within 30 mins (Fig. 2D). Building on this observation and
because necrosis of cells has been shown to activate inflamma-
somes [24], we examined whether IL-18 release was dependent on
caspase 1. The inhibitor caspase 1 reduced IL-18 release (Fig. 2E).
Together these studies indicate that ALT-E induces release of IL-
18 from airway epithelial cells by activating caspase 1 and
inducing necrosis.
IL-18 induces Th2 differentiation of naı ¨ve CD4
+ T cells
independent of IL-4 and STAT6
The intrinsic protease activity of ALT-E and its ability to induce
extracellular ATP can have direct effects on dendritic and T-cells to
induce Th2 differentiation [25–27]. Since our objective was to
determine the Th2-promoting effects of IL-18 that is rapidly and
specifically released from epithelial cells upon contact with ALT-E,
wedesigned experimentsthat didnotrequire directcontactofALT-
E with immune cells. This was achieved by adding rIL-18 to
purified naı ¨ve CD4+ T-cells and examining whether it could
provide sufficient signal required to induce Th2 differentiation.
Because CD4
+ T cells require interaction of IL-4 with IL-4R and
activation of STAT6 to induce Th2 differentiation [28,29], we
initially examined whether IL-18 could promote Th2 differentiation
by inducing secretion of IL-4. Indeed treatment of naı ¨ve splenocytes
with either 50 ng/ml IL-4 or 100 ng/ml of IL-18 for 8–10 hours
Figure 2. Induction of epithelial cell necrosis by ALT-E. (A) A549 cells were cultured with ALT-E for 30 min. Changes in cell morphology were
monitored by live cell imaging. (B) Time course of ALT-E-induced IL-18 release from airway epithelial cells. (C) Exposure of cultured A549 epithelial
cells to ALT-E induces cell necrosis. (D) ALT-E challenge of mice induces sloughing of trypan blue positive necrotic airway epithelial cells (n=4 per
group). (E) Caspase 1 inhibitor (Cas.1 inh.) reduces IL-18 release from A549 airway epithelial cells cultured with ALT-E.
doi:10.1371/journal.pone.0030280.g002
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we examined the ability of IL-18 to induce Th2 differentiation of
naı ¨ve CD4
+ T cells (Fig. 3B). As expected, culture of CD4
+ T cells
with plate-bound anti-CD3 and anti-CD28 in the presence IL-4
induced Th2 differentiation (Fig. 3C). Likewise, IL-18 also induced
Th2 differentiation of CD4
+T cells in a dose dependent manner
(Fig.3C).Takentogether,thedata inFig.3A–Csuggestthat IL-18
induces Th2 differentiation of naı ¨ve CD4
+ T-cells.
To examine the role of secreted IL-4 in mediating the Th2
differentiating effects of IL-18, CD4
+ T cells from IL-4
2/2 mice
were cultured with IL-18. IL-18 induced Th2 differentiation of
CD4
+ T cells from IL-4
2/2 mice (Fig. 3B), as indicated by the
secretion of IL-5, IL-10, IL-13 (Fig. 3D). These observations
indicate that IL-18 induces Th2 differentiation independent of IL-
4. Since STAT6 is required for inducing Th2 differentiation
[28,29], we examined the role of STAT6 in mediating IL-18 in
Figure 3. Effect of IL-18 on induction of Th2 differentiation. (A) Effect of IL-18 on IL-4 secreting splenocytes ELISPOTS. (B) T cell differentiation
protocol used in Panels 3C–E and Fig. 4. (C, D and E) Effect of IL-18 or IL-4 on Th2 differentiation of naı ¨ve CD4+ T-cells isolated from WT mice (C), IL-
4
2/2 mice (D) and WT and STAT6
2/2 mice (E). n=527 per group.
doi:10.1371/journal.pone.0030280.g003
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+ T cells derived from WT mice
and STAT6
2/2 mice were cultured with IL-18. As expected,
culture of STAT6
+/+ T-cells with 50 ng/ml of IL-4 in the
differentiation phase induced IL-4 and IL-5 release upon
polyclonal restimulation, and these effects were abrogated by
disruption of STAT6 (Fig. 3E). Likewise, culture of STAT6
+/+
CD4
+ T-cells with IL-18 in the differentiation phase induced IL-4
and IL-5 release upon polyclonal restimulation. Surprisingly, these
effects of IL-18 were not completely abrogated by disruption of
STAT6 (Fig. 3E). These results indicate that IL-18 can promote
Th2 differentiation of naı ¨ve CD4
+ T cell even in the absence of IL-
4 and STAT6.
IL-18 induces Th2 differentiation via NF-kB
Prior studies have shown that IL-18 signals through MyD88 [30]
and activates NF-kB [31]. Furthermore, NF-kB p50 plays a critical
role in allergic sensitization and asthma [32]; however, to our
knowledge, Th2 differentiation of CD4
+ T cells via NF-kB has not
been described. Here we found that culture of naı ¨ve T-cell derived
from WT mice with IL-18 under non-skewing conditions induced a
significant increase of IL-4 (Fig. 4A), IL-5 (Fig. 4B), and IL-13
(Fig. 4C), indicating Th2 differentiation. These effects of IL-18
were abrogated in NF-kBp 5 0
2/2 mice. Because disruption of NF-
kB p50 could alter T-cells in unforeseen ways that could explain
these observations, we wished to confirm our observations in T-cells
from wild-type mice using a specific inhibitor of the NF-kB
pathway. To achieve this objective, we compared the evaluated the
effect of culture of CD4+ T-cells in the presence or absence of
NEMO-Binding Domain Binding Peptide (Fig. 5 A–C) in a T-cell
differentiation assay. In the absence of NEMO inhibitor, IL-18
vigorously increased (20-fold) IL-4 and IL-5 secretion (Fig. 5A and
Fig. 5B) from restimulated cells; these effects were inhibited by
NEMO peptide inhibitor. As the experiments were performed
under non-skewing conditions, it is not surprising that IL-18
treatment also induced a modest 3-fold increase in IFN-c secretion
(Fig. 5C). Importantly, IL-18 treatment increased GATA3
expression in 66% of CD3
+CD4
+ T-cells (Fig. 5F). Taken together,
these results indicate that IL-18 induces Th2 differentiation via a
novel NF-kB p50-dependent pathway.
Discussion
Multicenter epidemiologic studies such as CAMP, NHANES II
and III have reproducibly shown that Alternaria sensitization is
associated with allergic asthma, but the mechanism of this specific
association remains a scientific enigma [3–6]. Here we show that
exposure of NHBE cells and the airways of naı ¨ve mice to ALT-E
rapidly induces the release of IL-18, but not other Th2 associated
cytokines such as IL-4, IL-9, IL-13, IL-25, IL-33 or TSLP.
Furthermore, when compared to 19 other major outdoor allergens
examined in these multicenter epidemiologic studies, Alternaria
extracts released the greatest amounts of IL-18 from airway
epithelial cells than the other outdoor allergens. Importantly,
release of IL-18 was associated with damage to these airway
epithelial cells. The GABRIEL consortium study predicted
environmentally induced epithelial damage to activate the
adaptive immune system and induce allergic airway inflammation
and asthma [2]. Our results suggest that Alternaria exposure
damages the airway epithelium and releases IL-18, and this release
may be one of the mechanisms of initiation of asthma.
Furthermore, the consortium study identified protective effects of
single nucleotide polymorphisms (SNPs) in IL-18R against asthma,
suggesting pro-asthma effects of wild-type IL-18R, which is also
consistent with our study [2].
Figure 4. Effect of disruption of NF-kB p50 on Th2 differenti-
ation of naı ¨ve CD4 T-cells treated with IL-18. CD4
+ T-cells from
Wild-type (WT) and NF-kB p50
2/2 mice were cultured with IL-18 in the
differentiation phase, restimulated with con A, and secretion of IL-4 (A),
IL-5 (B) and IL-13 (C) was quantified by ELISA. n=527 per group.
doi:10.1371/journal.pone.0030280.g004
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18 within minutes of exposure to ALT-E, and this release was
associated with epithelial cell necrosis. The protease activity of
fungi has been shown to induce Th2 inflammation [25,26,33] and
increase TSLP secretion via PAR2 receptor in human BEAS2B
cells in 12 hrs [25]. Another recent report suggested that Alternaria
induces release of IL-33 into the murine airway lumen, followed
by Th2-type responses [27]. However, in our study that utilized
physiologically relevant human NHBE cells, ALT-E increased IL-
18 but not TSLP or IL-33 levels in 15 mins. The much shorter
time frame in our study and the various epithelial cells studied may
account for the differences in these studies. It is unlikely that the
protease activity of ALT-E contributed to IL-18 release in our
study because broad spectrum protease inhibitors failed to inhibit
IL-18 release, and high protease allergens such as American
cockroach or house dust mite did not increase its secretion. The
more likely explanation for IL-18 release in our study is that ALT-
E induces rapid necrotic change in epithelial cells. Necrotic cell
death has been shown to activate the NLRP3 inflammasomes that
convert pro-IL-18 to IL-18 by activating caspase 1 [24]. Our
observations indicate that an inhibitor of caspase 1 decreases levels
of IL-18 release. Future studies should carefully evaluate whether
inflammasome or other mechanisms play a role in Alt-E induced
rapid release of IL-18 from airway epithelial cells.
A prior report indicated that IL-18 promotes Th2 differentia-
tion by inducing secretion of IL-4 [34]. Consistent with that
report, we show here that IL-18 induced IL-4 secretion from T-
cells. However, our results also indicate that IL-18 can induce Th2
differentiation independent of IL-4. Since both studies utilized
similar doses of IL-18 to stimulate T-cells, these two different
observations cannot be rationalized by differences in IL-18 dose
used in the two studies. In the prior study, the Th2 differentiation
promoting effects of IL-4 were evaluated by using 11B11
neutralizing antibody against IL-4 [34]. In contrast, here we
utilized a more rigorous approach by using CD4
+ T cells from IL-
4
2/2 mice. It is possible that this difference in extent of IL-4
blockade in the two studies could account for the difference in final
observations.
In the present study, we show that IL-18 can induce Th2
differentiation even in the absence of STAT6. These observations
were very surprising because elegant studies have reported that
IL-4 and STAT6 are indispensable for inducing Th2 differenti-
ation [28,29]. T cells lacking IL-4 and Stat6 have been shown to
express higher levels of IL-18Ra after T-cell Receptor (TCR)
stimulation, a key driving factor for Th1 induction [35].
However, the mechanism of Th2 differentiation is unlikely to
be due to downregulation IL-18Ra expression by IL-4 because
we show Th2 differentiation in the absence of IL-4 [35]. Because
GATA3 expression in the absence of STAT6 is sufficient to
induce Th2 differentiation [36], and our data in the present study
indicates that IL-18 can increase GATA3 expression, the most
likely mechanism of th2 induction is increased GATA3
expression.
Previous reports indicated that mice deficient in the p50 subunit
of NF-kB show reduced eosinophilic airway inflammation
compared with wild-type mice. This deficiency was not due to a
block in T cell priming or proliferation in the p50
2/2 mice
[32,37]. Here we show that the Th2 differentiating effects of IL-18
are inhibited in the absence of NF-kB p50, or by inhibiting NF-kB
pathway in wild type T-cells using a NEMO binding peptide
inhibitor. It is consequently likely that in vivo Th2 promoting
effects of IL-18 will be blocked by inhibitors of this pathway.
In the present study, IL-18 induced a slight increase in IFN-c
secretion from restimulated CD4 cells. Because these experiments
were performed under non-skewing conditions, without using
neutralizing antibodies against IFN-c or IL-12, these culture
conditions likely account for this slight increase in IFN-c. These
observations are consistent with our earlier work showing that
intrapulmonary administration of IL-18 with an allergen in mice
promotes allergic sensitization and Th2 phenotype, and IFN-c
induction by IL-18 has short-term inhibitory effects on allergic
inflammation that disappears by three weeks of administration,
Figure 5. Effect of IL-18 on Th2 differentiation and GATA3 expression in naı ¨ve CD4+ T-cells. (A,B,C). Effect of NEMO peptide on Th2
differentiation. Negatively selected naı ¨ve CD3
+ CD4
+ T-cells were cultured with plate bound anti-CD3 and anti-CD28 with PBS (PBS), IL-18 100 ng/ml
(IL-18), IL-18 100 ng/ml and 10 mM NEMO Binding Domain Binding Peptide (IL-18+NEMO) for the initial culture period. The cells were washed and
restimulated, and secretion of IL-4 (A), IL-5 (B) and IFN-c(C) were quantified. The data was expressed as fold increase compared to cells cultured with
PBS. (D,E,F). GATA3 expression in T-cells. Negatively selected naı ¨ve CD3
+ CD4
+ T-cells were cultured with plate bound anti-CD3 and anti-CD28 in the
presence of PBS (D), IL-4 (E) or IL-18 (F) for 7 days. GATA3 expression was measured by flow cytometric analysis.
doi:10.1371/journal.pone.0030280.g005
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are long lasting [38].
In summary, we provide evidences that exposure to an extract
of Alternaria alternata has the ability to rapidly induce epithelial cell
necrosis and specifically release IL-18. This effect of Alternaria on
epithelial cells may involve conditioning of DC [39,40], and the
released IL-18 is likely to contribute to the development of allergic
asthma by its ability to induce Th2 differentiation by a novel NF-
kB-dependent pathway. We suggest that these molecular pathways
could be one of the pathways that link epithelial cell damage to
asthma as hypothesized in the GABRIEL consortium study [2],
and explain the reproducible association between Alternaria
sensitization and allergic asthma in the CAMP and NHANES
studies.
Materials and Methods
Cell cultures and treatments
Primary normal human bronchial epithelial (NHBE) cells
(Cambrex Bio Science, Walkersville, Maryland) were cultured in
BEGMH BulletKitH medium supplied by the manufacturer
(Lonza, Switzerland). NHBE cells were maintained as previously
described [41]; 2–4 passages of NHBE cells were used for this
study. A549 bronchial epithelial cells were obtained from the
American Type Cell Collection and cultured in Ham’s F-12
medium at 37uC in a humidified atmosphere with 5% CO2. For
experiments cells were subcultured into 96 well plates and exposed
to 30 mg/ml of various endotoxin-free allergens for 15 min;
supernatants were collected and analyzed using cytokine ELISA
assays. Caspase-1 inhibitor I (Calbiochem, Gibbstown, NJ),
10 uM, was added to 1610
5 A549 cells for 1 hr before exposure
to 30 mg/ml of ALT-E stimulation.
Allergens
The allergens tested were the identical outdoor allergen panel
that was examined in the NHANES and CAMP studies, consisting
of Alternaria, Aspergillus, Penicillium, Cotton wood, Elm, Elder,
Mountain Cedar, Olive, Tag Alder, Walnut, White Oak, Bermuda
Grass, Fire Bush, Short Ragweed, Russian thistle, Perennial rye
grass, Pigweed, Sage grass and Timothy grass (Greer, NC, USA).
Live cell imaging for cell necrosis
Morphologic changes were continuously monitored and re-
corded at 37uCi n5 %C O 2 using NIKON live-cell imaging
microscopy (NIKON Eclipse TE200).
Flow cytometry for cell necrosis and apoptosis
A549 cells were cultured with 30 mg/ml allergen extract at 37uC
in 5% CO2 and analyzed for cell necrosis and apoptosis using
Annexin-V Apoptosis detection kit 1 (BD Pharmingen, San Diego,
CA) according to company’s protocol. A minimum of 15,000 cells
were analyzed using Beckman Coulter Quanta for FACS.
Animals
Eight weeks old BALB/c mice purchased from Harlan Sprague
Dawley (Indianapolis, IN). Stat6
2/2 and IL-4
2/2 on BALB/c
background were purchased from Jackson laboratory (Bar Harbor,
Maine). The NF-kB p50
2/2 mice and their controls were
purchased from the Jackson Laboratory. All mice were housed
in a pathogen-free environment throughout the experiment at The
University of Texas Medical Branch at Galveston. The Institu-
tional Animal Care and Use Committee of The University of
Texas Medical Branch at Galveston approved all animal
experiments (IACUC Approval ID: 9708038A).
Bronchoalveolar lavage (BAL)
Bronchoalveolar lavage was performed as previously described
[42,43]. Mice were euthanized with an intraperitoneal injection of
ketamine and xylazine, and challenged intranasally with 20 mg/ml of
ALT-E, or PBS. After 1 hr, the BALF were obtained by cannulating
the trachea and lavaging the lungs with two 0.75 ml aliquots of ice-
cold Dulbecco’s PBS (Sigma, St. Louis, MO). The cells in BAL fluids
were pelleted and the number of trypan blue positive ciliated
epithelial cells were quantified by counting cells in a hemocytometer.
Thecytokineslevelsincell-freeBALfluidswerequantifiedbyELISA.
Purification of naı ¨ve CD4
+ T cells
Spleen were dissected from naı ¨ve mice, washed with PBS twice,
and separated into cells using 70 mm cell strainer (BD falcon,
Sanjose CA). T cells were negatively purified with T cell Isolation
kit II and Auto MACS separater (Militenyi Biotech, Germany,
.95% pure).
ELISA for cytokines
Two-site immunoenzymetric assays were used to measure IFN-c,
IL-4, IL-9, IL-13, IL-18, IL-25, IL-33, and TSLP. Human IL-18
was measured using capture antibody clone number 159-12B, and
the detection antibody clone 125-2H (R and D Systems). Human
IL-4, IL-13, IL-33 and TSLP were measured by ELISA Kits (R&D
Systems, Minneapolis, MN). Murine IL-4, IL-9, IL-10 and IL-18
weremeasured usingcapture antibodyclone numbers 11B11 (IL-4),
D8402E8 (IL-9), JES5-2A5 (IL-10); and the detection antibody
clone numbers were BVD6-24G2 (IL-4), D9302C12 (IL-9), JES5-
16E3 (IL-10) (all purchased from BD Biosciences), and IL-18
captureantibodyclone74anddetectionantibodyclone93–10 C(R
and D Systems). Mouse IL-13, IL-25, IL-33 and TSLP were
measured by DuoSet Kits (R&D systems, Minneapolis. MN).
ELISPOT for IL-4-secreting cells
ELISPOT for IL-4 secreting cells were undertaken as previously
described [43]. Briefly, Immulon 2 microtiter plates (96-well) were
coated with anti-IL-4 (clone BVD4-1D11, Endogen, Woburn, MA).
Serial dilutions of spleen cells, ranging from 1610
5 to 10610
5 cells/
well, were incubated on anti-cytokine-coated plates for 8–10 h at
37uC in a humidified 5% CO2 incubator. Plates were then washed
and overlaid with biotinylated anti-IL-4 (clone BVD6- 24G2,
Endogen), washed, and treated with a 1:2000 dilution of avidin
conjugated alkaline phosphatase (Vector Laboratories, Burlingame,
CA) for 2 hrs at room temperature. After a final wash, the cytokine
products of individual secreting cells were visualized by the addition
of a solution of 5-bromo-4-chloro-3-indolyl phosphate/nitroblue
tetrazolium (Kirkegaard and Perry, Gaithersburg, MD).ELISPOTs
were counted with the aid of a dissecting microscope and expressed
as ELISPOTs per million cells.
Th2 differentiation assays
Briefly, negatively selected Naı ¨ve CD4
+ T cells (.95% pure,
negatively selected) were cultured in wells precoated with 1 mg/ml
anti-CD3 and anti-CD28 for 7 days with a range of IL-18 (1–
100 ng/ml) and an IL-4 concentration of 1 ng/ml. IL-2 (50 U/
ml) was added to all wells after 24 hr. The cells were extensively
washed and restimulated with Con A for 24 hr. The supernatants
were analyzed IL-4, IL-5, and IL-13 by ELISA.
Th2 differentiation assays with NEMO-Binding Domain
Binding Peptide inhibitor
Negatively selected murine CD4+ T cells were cultured with
plate bound anti-CD3 and anti-CD28 as outlined (see Fig. 3B
The Role of IL-18 from Airway Epithelial Cell
PLoS ONE | www.plosone.org 7 February 2012 | Volume 7 | Issue 2 | e30280above) along with PBS, or IL-18 (100 ng/ml) or IL-18+NEMO-
Binding Domain Binding Peptide (NEMO, 10 mM) and subjected
to analysis outlined above.
Flow cytometric analysis for GATA3 expression in CD4+ T
cells
CD4
+ T-cells were cultured with plate bound anti-CD3 and
anti-CD28 along with PBS, IL-4 20 ng/ml, or IL-18 (100 ng/ml)
for 7 days. The cells were harvested and subjected to flow
cytometric analysis for GATA3 expression. CD3+ (FITC) CD4+
(PE-Cy5) T-cells were gated and analyzed for GATA3 expression
shown on the X-axis. All FACS antibodies were purchased from
BD Biosciences, San Diego, CA.
Statistics
Data from different treatment groups were analyzed by
ANOVA, followed by Bonferroni post-hoc analyses for least
significant difference. Values in figures are expressed as mean 6
SEM. *P,0.05,**P,0.01,***P,0.001.
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